Every night, the online Belgian patent register ('eRegister') receives an update with public data that were entered or generated the preceding day on the Benelux Patent Platform, the computer application with which the Belgian Intellectual Property Office handles the registration, treatment and publication processes for patents and supplementary protection certificates.
Currently, some updates are spread over consecutive nights due to the large, weekly volume of data concerning European patents designating Belgium.
For a European patent it is possible that data about the inventor(s) are missing from the online Belgian patent register. They can be found via the link to the European patent register pending an update of the Belgian patent register.
For European patents with Unitary Effect, the authentic source of information is the European Patent Register : please refer to it.

Patent details

4017494 Title: L'INHIBITEUR DE VMAT2 VALBENAZINE POUR SON UTILISATION DANS UNE MÉTHODE DE TRAITEMENT D'UN TROUBLE NEUROLOGIQUE OU PSYCHIATRIQUE CHEZ DES PATIENTS PRÉSENTANT UNE INSUFFISANCE RÉNALE GRAVE

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic information

Application number:
207649104
WO application number:
US2020047392
Type:
European patent granted for BE
Status:
Open
Publication number:
4017494
WO publication number:
WO2021041208
1rst applicant's nationality:
Translation language:
EPO publication language:
English
SPC number:

Dates

Filing date:
21/08/2020
Grant date:
20/08/2025
EP publication date:
29/06/2022
WO publication date:
04/03/2021
Claims translation received date:
Translation received date (EP publication B1):
Translation received date (EP publication B2):
Translation received date (EP publication B3):
Registration date:
20/08/2025
EP B1 publication date:
20/08/2025
EP B2 publication date:
EP B3 publication date:
Lapsed date:
Expiration date (if granted and all annual fees paid):
21/08/2040

Applicant

Name:
Neurocrine Biosciences, Inc.
Legal Form:
From:
20/08/2025
Address:
6027 Edgewood Bend Court, San Diego, CA 92130, United States (US)
To:

Agent

Name:
NLO
Legal Form:
From:
28/08/2025
Address:
New Babylon City Offices Anna van Buerenplein 21A, 2595 DA DEN HAAG, Netherlands (NL)
To:

Inventor

1

Name:
LOEWEN, Gordon Raphael
Legal Form:
Address:
Solana Beach, California 92075, United States (US)

2

Name:
LUO, Sha Rosa
Legal Form:
Address:
San Diego, California 92130, United States (US)

Priority

1

Priority patent number:
202063028754 P
Priority date:
22/05/2020
Priority country:
United States (US)

2

Priority patent number:
201962890697 P
Priority date:
23/08/2019
Priority country:
United States (US)

Classification

IPC or IDT classification:
A61K 31/4738; A61P 13/12; A61P 25/00; A61P 25/14; A61P 25/16; A61P 25/24; A61P 25/28; A61K 9/00;

Publication

Bulletin

Bulletin heading:
EP2
Journal edition number:
2025/16
Publication date:
17/10/2025
Description:
Contains data concerning European patents granted and published (B1 publication) for Belgium and for which no translation needed to be filed

European Patent Bulletin

1

Issue number:
202534
Publication date:
20/08/2025
Description:
Grant (B1)

2

Issue number:
202537
Publication date:
10/09/2025
Description:
Application number/publication number of the divisional application (Art. 76) changed

Annual fee

Annual fee(s) Due Date:
31/08/2026
Annual fee number:
7
Annual fee amount:
110 Euro
Expected payer:
Last annual fee payment date:
26/09/2025
Last annual fee paid number:
6
Last annual fee paid amount:
95 Euro
Payer:
CABINET BEDE
Filing date Document type Publication Type Document Description Number of pages File Type
28/08/2025 General Document Declaration of domicile 2 PDF /5/1/8/0/7/0722570815/docs/207649104_0_generaldocument_20250829_084537779.pdf
28/08/2025 Incoming Correspondence (Email) Cover letter 1 PDF /5/1/8/0/7/0722570815/docs/207649104_1_incomingcorrespondenceelectronic_20250829_084537939.pdf
28/08/2025 Outgoing Correspondence 1 PDF /5/1/8/0/7/0722570815/docs/207649104_2_outgoingcorrespondence_20250829_084537656.pdf